Skip to content

Current ratio at other companies

Bit Digital logo
Bit DigitalBTBT
6.4×+2.5×
Scilex Holding Company logo
Scilex Holding CompanySCLX
0.1×0.0×
TEC
Bio-TechneTECH
4.5×+0.8×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
Medtronic logo
MedtronicMDT
2.1×+0.3×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.2×-2.8×

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity

Where this comes from

Calculated from BioSig Technologies, Inc.’s reported figures.

Based on the most recent quarter.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s current ratio?
BioSig Technologies, Inc. (STEX) reported current ratio of 13.9× in Q1 2026.
How has BioSig Technologies, Inc.'s current ratio changed year-over-year?
BioSig Technologies, Inc.'s current ratio increased by 485.6% year-over-year, from 2.4× to 13.9×.
What is the long-term trend for BioSig Technologies, Inc.'s current ratio?
Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s current ratio has grown at a -21.8% compound annual growth rate (CAGR), from 5.7× to 1.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.